0004-2927

Ars Pharmaceutica (Internet)

Editorial de la Universidad de Granada

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Deposit reference lists for 216 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact216 DOIs
2

Attach ORCID iDs across 136 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact136 DOIs
3

Add license metadata to 123 records

License metadata tells indexers and readers how each article may be reused.

Medium impact123 DOIs

DOIs for this ISSN

Showing the top 5 of 323 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Protein and Peptide in Drug Targeting and its Therapeutic Ap… (10.4321/s2340-98942015000300006)
Abstract References ORCID License
132.22 20
2 Métodos para medir la adherencia terapeútica (10.30827/ars.v59i3.7387)
References ORCID License
124.71 45
3 Proliposomes: An Approach for the Development of Stable Lipo… (10.30827/ars.v60i4.8517)
References ORCID License
117.62 36
4 Dietary antioxidants for chronic periodontitis prevention an… (10.4321/s2340-98942015000300001)
Abstract References ORCID License
111.39 12
5 An Alternative Approach for Acetylation of Amine Terminated… (10.4321/s2340-98942015000300004)
Abstract References ORCID License
111.39 12
6 Adherencia terapéutica: factores modificadores y estrategias… (10.30827/ars.v59i4.7357)
References ORCID License
104.85 24
7 Comparación de las propiedades antioxidantes y contenido de… (10.4321/s2340-98942015000200003)
Abstract References ORCID License
104.14 10
8 Prescribing pattern of antihypertensive drugs in diabetic pa… (10.4321/s2340-98942015000200005)
Abstract References ORCID License
104.14 10
9 Quality by design (QbD) approach to formulate in situ gellin… (10.30827/ars.v58i3.6528)
References ORCID License
102.13 22
10 Microorganismos probióticos y salud (10.4321/s2340-98942015000100007)
Abstract References ORCID License
100.00 9
11 Development and characterization of a novel nano-liposomal f… (10.30827/ars.v59i1.7274)
References ORCID License
90.31 15
12 Pharmacology of Natural Products: An recent approach on <… (10.30827/ars.v59i1.7276)
References ORCID License
90.31 15
13 Isoflavonoids from the rhizomes of Iris hungarica and antiba… (10.30827/ars.v58i1.5919)
References ORCID License
88.21 14
14 A simple route for preparation of pH-sensitive hydrogels by… (10.30827/ars.v58i3.6530)
References ORCID License
88.21 14
15 Self-Micro Emulsifying Drug Delivery Systems: A Strategy to… (10.30827/ars.v57i3.5327)
References ORCID License
85.96 13
16 Aproximación al tratamiento del envejecimiento cutáneo (10.4321/s2340-98942015000400001)
Abstract References ORCID License
84.51 6
17 Development and Optimization of Amoxicillin Floating Raft Sy… (10.30827/ars.v61i3.13718)
References ORCID License
80.94 11
18 Efecto neuroprotector de los cannabinoides en las enfermedad… (10.4321/s2340-98942015000200002)
Abstract References ORCID License
77.82 5
19 Protección cardiovascular con flavonoides: enigma farmacocin… (10.4321/s2340-98942015000400002)
Abstract References ORCID License
77.82 5
20 Miconazole Microsponges based topical delivery system for di… (10.30827/ars.v57i2.4987)
References ORCID License
71.57 8
21 Efecto de compuestos fitoquímicos del género Allium sobre el… (10.30827/ars.v59i3.7479)
References ORCID License
71.57 8
22 Formulation of mucoadhesive microspheres of rosiglitazone ma… (10.4321/s2340-98942015000200004)
Abstract References ORCID License
69.90 4
23 Studies of ternary systems of sulfadiazine with β-cyclodextr… (10.30827/ars.v57i4.5561)
References ORCID License
67.73 7
24 Ácido glicirrícico: extracción, cribado y evaluación de la p… (10.30827/ars.v59i2.7513)
References ORCID License
67.73 7
25 Formulación y evaluación de ketoprofeno cargado de nanogel d… (10.30827/ars.v60i2.8563)
References ORCID License
67.73 7
26 Errores de medicación en pacientes hospitalizados: una revis… (10.30827/ars.v62i2.16166)
References ORCID License
67.73 7
27 Hospital effluent constitutes a source of vancomycin-resista… (10.30827/ars.v57i3.5329)
References ORCID License
63.38 6
28 Polypharmacy as a risk factor for depressive symptoms in ger… (10.30827/ars.v57i3.5330)
References ORCID License
63.38 6
29 Immobilization and microencapsulation of Lactobacillus casei… (10.30827/ars.v58i4.6765)
References ORCID License
63.38 6
30 Equipo multidisciplinar de atención al paciente crítico: ¿qu… (10.30827/ars.v59i3.7584)
References ORCID License
63.38 6
31 Formulation and evaluation of baclofen liposome vesicles usi… (10.30827/ars.v61i3.15279)
References ORCID License
63.38 6
32 Intervenciones farmacéuticas: desarrollo e implementación me… (10.4321/s2340-98942015000300003)
Abstract References ORCID License
60.21 3
33 Stability of spray-dried chitosan salts derived from lobster… (10.4321/s2340-98942015000400005)
Abstract References ORCID License
60.21 3
34 Development and Evaluation of Isoniazid Loaded Silk Fibroin… (10.30827/ars.v57i3.5331)
References ORCID License
58.36 5
35 Historia y actualidad de productos para la piel, cosméticos… (10.30827/ars.v58i1.5915)
References ORCID License
58.36 5
36 Liposomal delivery of 5 Fluorouracil and Tretinoin: An Aspec… (10.30827/ars.v60i3.7966)
References ORCID License
58.36 5
37 Nanopartículas poliméricas de administración intranasal para… (10.30827/ars.v57i1.4384)
References ORCID License
52.42 4
38 Synthesis and cytotoxic activity of tri-acyl ester derivativ… (10.30827/ars.v57i4.5560)
References ORCID License
52.42 4
39 Synthesis and cytotoxic activity of per-acetylated and halog… (10.30827/ars.v58i4.6441)
References ORCID License
52.42 4
40 Adverse reactions for the use of the monoclonal trastuzumab… (10.30827/ars.v58i4.6766)
References ORCID License
52.42 4
41 Activos antioxidantes en la formulación de productos cosméti… (10.30827/ars.v59i2.7218)
References ORCID License
52.42 4
42 Atención Farmacéutica en adultos mayores hipertensos. Una ex… (10.30827/ars.v59i2.7307)
References ORCID License
52.42 4
43 La evaluación axiológica de los Proyectos en los Comités de… (10.4321/s2340-98942015000200007)
Abstract References ORCID License
47.71 2
44 Especies de Ulva del Golfo San Jorge, Patagonia Argentina: v… (10.30827/ars.v57i2.4965)
References ORCID License
45.15 3
45 Diseño, síntesis y estudio de acoplamiento molecular de híbr… (10.30827/ars.v59i3.7360)
References ORCID License
45.15 3
46 Cribado de la actividad hipoglucémica in vitro de Murraya ko… (10.30827/ars.v59i3.7413)
References ORCID License
45.15 3
47 Proceso de agotamiento de las células T durante la infección… (10.30827/ars.v60i2.9432)
References ORCID License
45.15 3
48 Design and Characterization of Combinational Domperidone-Fam… (10.30827/ars.v62i2.15810)
References ORCID License
45.15 3
49 Preparation and characterization of topical solid lipid nano… (10.30827/ars.v62i3.15493)
References ORCID
45.15 7
50 Análisis y evaluación de resultados tras la implantación de… (10.30827/ars.v57i2.4958)
References ORCID License
35.78 2